Download Thelan`s Critical Care Nursing

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
CHAPTER 20
Kidney Disorders and Therapeutic
Management
ACUTE KIDNEY INJURY
Acute kidney injury (AKI)
 Critical illness and AKI
Longer hospital stay, more complications, and
higher mortality
Multisystem dysfunctions
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
2
ACUTE KIDNEY INJURY (CONT.)
Definitions of AKI
 RIFLE criteria
 Acute Kidney Injury Network (AKIN) criteria
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
3
ACUTE KIDNEY INJURY (CONT.)
Types of AKI
 Prerenal acute kidney injury
 Intrarenal acute kidney injury
 Postrenal acute kidney injury
Azotemia
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
4
QUICK QUIZ!
Any condition that decreases blood flow, blood pressure, or kidney
perfusion before arterial blood reaches the renal artery that supplies the
kidney may be anatomically described as which kind of AKI?
A. Prerenal
B. Intrarenal
C. Postrenal
D. Both A & B
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
5
ASSESSMENT AND DIAGNOSIS
Laboratory assessment
 Acidosis
 Blood urea nitrogen (BUN)
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
6
ASSESSMENT AND DIAGNOSIS (CONT.)
Laboratory assessment (Cont.)
 Serum creatinine
 Creatinine clearance
 Fractional excretion of sodium (FENa)
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
7
AT-RISK DISEASE STATES AND ACUTE
KIDNEY INJURY
Underlying chronic kidney disease (CKD)
Older age and AKI
Heart failure and AKI
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
8
AT-RISK DISEASE STATES AND ACUTE
KIDNEY INJURY (CONT.)
Respiratory failure and AKI
Sepsis and AKI
Trauma and AKI
 Trauma admissions
 Rhabdomyolysis
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
9
AT-RISK DISEASE STATES AND ACUTE
KIDNEY INJURY (CONT.)
Contrast-induced nephrotoxic injury and AKI
 Radiopaque contrast
 Promote hydration and avoid dehydration
 Medications
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
10
AT-RISK DISEASE STATES AND ACUTE
KIDNEY INJURY (CONT.)
Catheter-associated urinary tract infection (CAUTI)
Hemodynamic monitoring and fluid balance
 Hemodynamic monitoring
 Daily weight
 Physical assessment
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
11
QUICK QUIZ!
A 1-kg weight gain over 24 hours represents how many units of additional
fluid retention?
A. 10 mL
B. 100 mL
C. 1000 mL
D. 2000 mL
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
12
AT-RISK DISEASE STATES AND ACUTE
KIDNEY INJURY (CONT.)
Electrolyte balance
 Potassium
 Sodium
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
13
AT-RISK DISEASE STATES AND ACUTE
KIDNEY INJURY (CONT.)
Electrolyte balance (Cont.)
 Calcium and phosphorus
 Calcium replacement
 Dietary-phosphorus–binding medications
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
14
AT-RISK DISEASE STATES AND ACUTE
KIDNEY INJURY (CONT.)
Medical management
 Treatment goals
 Prevention
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
15
AT-RISK DISEASE STATES AND ACUTE
KIDNEY INJURY (CONT.)
Medical management (Cont.)
 Fluid resuscitation
Crystalloids
Colloids
 Fluid restriction
 Fluid removal
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
16
AT-RISK DISEASE STATES AND ACUTE
KIDNEY INJURY (CONT.)
Pharmacologic management
 Diuretics
Loop diuretics
Thiazide diuretics
Osmotic diuretics
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
17
AT-RISK DISEASE STATES AND ACUTE
KIDNEY INJURY (CONT.)
Pharmacologic management (Cont.)
 Diuretics (Cont.)
Carbonic anhydrase inhibitor diuretics
Potassium-sparing diuretics
Vaptans
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
18
AT-RISK DISEASE STATES AND ACUTE
KIDNEY INJURY (CONT.)
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
19
AT-RISK DISEASE STATES AND ACUTE
KIDNEY INJURY (CONT.)
Pharmacologic management (Cont.)
 Dopamine
 Acetylcysteine
 Dietary-phosphorus binders
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
20
AT-RISK DISEASE STATES AND ACUTE
KIDNEY INJURY (CONT.)
Nutrition
Nursing management
 Risk factors for AKI
 Infectious complications
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
21
AT-RISK DISEASE STATES AND ACUTE
KIDNEY INJURY (CONT.)
Nursing management (Cont.)
 Fluid balance
 Electrolyte imbalance
 Preventing anemia
Erythropoiesis-stimulating medications
 Patient education
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
22
RENAL REPLACEMENT THERAPY:
DIALYSIS
Hemodialysis
 Hemodialyzer
 Ultrafiltration
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
23
RENAL REPLACEMENT THERAPY:
DIALYSIS (CONT.)
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
24
RENAL REPLACEMENT THERAPY:
DIALYSIS (CONT.)
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
25
RENAL REPLACEMENT THERAPY:
DIALYSIS (CONT.)
Hemodialysis
(Cont.)
 Anticoagulation
 Vascular access
Temporary
vascular access
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
26
RENAL REPLACEMENT THERAPY:
DIALYSIS (CONT.)
Permanent
vascular access
 Arteriovenous fistula
 Arteriovenous graft
 Tunneled catheters
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
27
RENAL REPLACEMENT THERAPY:
DIALYSIS (CONT.)
Medical management
Nursing management
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
28
RENAL REPLACEMENT THERAPY:
DIALYSIS (CONT.)
Continuous renal replacement therapy (CRRT)
 May continue over several days
 Hemofilter
 Electric roller pump
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
29
RENAL REPLACEMENT THERAPY:
DIALYSIS (CONT.)
CRRT (Cont.)
 Continuous Renal Replacement Therapy Terminology
Diffusion
Convection
Absorption
Ultrafiltrate volume
Replacement fluid
Anticoagulation
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
30
RENAL REPLACEMENT THERAPY:
DIALYSIS (CONT.)
CRRT (Cont.)
 Modes of continuous renal replacement
Slow continuous ultrafiltration (SCUF)
Continuous venovenous hemofiltration (CVVH)
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
31
RENAL REPLACEMENT THERAPY:
DIALYSIS (CONT.)
Peritoneal dialysis (PD)
 Dialysate
 Infusion
 Drainage
 Dwell time
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
32
RENAL REPLACEMENT THERAPY:
DIALYSIS (CONT.)
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
33
RENAL REPLACEMENT THERAPY:
DIALYSIS (CONT.)
PD (Cont.)
 PD catheter
placement
 Infection
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
34
RENAL REPLACEMENT THERAPY:
DIALYSIS (CONT.)
PD (Cont.)
 Medical management
 Nursing management
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
35
SUMMARY
AKI
 AKI risk factors include sepsis, cardiac surgery, and diabetes.
 Many critically ill patients have AKI as a complication of their illness; if AKI
develops, mortality and morbidity rates increase.
 Vigorous hydration with normal saline is the most effective intervention to
prevent contrast-induced neuropathy and AKI.
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
36
SUMMARY (CONT.)
CAUTI
 CAUTI remains a significant risk in critical illness.
 Prevention strategies include avoiding unnecessary use of urinary catheters;
insertion of urinary catheters using aseptic technique; adoption of evidencebased standards for maintenance of urinary catheters; daily clinical review of
the need for the urinary catheter and, if not needed, prompt removal.
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
37
SUMMARY (CONT.)
Diuretics and renal replacement therapies
 Diuretics increase urine output.
 Diuretics are categorized into different groups on the basis of their
pharmacology and site of action in the nephron.
 Acute care renal replacement therapies include IHD and CRRT.
COPYRIGHT © 2016 BY MOSBY, AN IMPRINT OF
ELSEVIER INC.
38
Related documents